Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes | Zendy

Hertzel C. Gerstein | Zendy; Michael E. Miller | Zendy; Saul Genuth | Zendy; Faramarz Ismail-Beigi | Zendy; John B. Buse | Zendy; David C. Goff | Zendy; Jeffrey L. Probstfield | Zendy; William C. Cushman | Zendy; Henry N. Ginsberg | Zendy; J. Thomas Bigger | Zendy; Richard H. Grimm | Zendy; Robert P. Byington | Zendy; Yves Rosenberg | Zendy; William T. Friedewald | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

Author(s) -

Hertzel C. Gerstein,

Michael E. Miller,

Saul Genuth,

Faramarz Ismail-Beigi,

John B. Buse,

David C. Goff,

Jeffrey L. Probstfield,

William C. Cushman,

Henry N. Ginsberg,

J. Thomas Bigger,

Richard H. Grimm,

Robert P. Byington,

Yves Rosenberg,

William T. Friedewald

Publication year - 2011

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1006524

Subject(s) - medicine , diabetes mellitus , intensive care medicine , type 2 diabetes , disease , intensive care , term (time) , endocrinology , physics , quantum mechanics

Intensive glucose lowering has previously been shown to increase mortality among persons with advanced type 2 diabetes and a high risk of cardiovascular disease. This report describes the 5-year outcomes of a mean of 3.7 years of intensive glucose lowering on mortality and key cardiovascular events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research